Rachel Maddox Schek, Scott J Hollister, Paul H Krebsbach 

Slides:



Advertisements
Similar presentations
One-Step Fabrication of Bone Morphogenetic Protein-2 Gene-Activated Porous Poly-L- Lactide Scaffold for Bone Induction  Jingwen Xue, Hang Lin, Allison.
Advertisements

Volume 9, Issue 2, Pages (February 2004)
BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium- derived progenitor cells cultured in three-dimensional alginate hydrogel 
Volume 8, Issue 2, Pages (August 2003)
Volume 6, Issue 5, Pages (November 2002)
Volume 11, Issue 2, Pages (February 2005)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
Volume 9, Issue 5, Pages (May 2004)
CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses  A. Reyes-Sandoval,
Targeted adenoviral gene transfer to the kidney
Volume 11, Issue 2, Pages (February 2005)
Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis  L. Pesesse, C. Sanchez, J.-P. Delcour, A. Bellahcène,
S. Varghese, Ph. D. , P. Theprungsirikul, B. S. , S. Sahani, B. S. , N
Volume 26, Issue 1, Pages (January 2018)
Volume 9, Issue 6, Pages (June 2004)
Volume 14, Issue 1, Pages (July 2006)
Volume 9, Issue 4, Pages (April 2004)
Volume 26, Issue 2, Pages (February 2018)
Volume 13, Issue 1, Pages (January 2006)
Volume 13, Issue 4, Pages (April 2006)
Volume 19, Issue 1, Pages (January 2011)
E. Farrell, P. Wielopolski, P. Pavljasevic, N. Kops, H. Weinans, M. R
Volume 9, Issue 4, Pages (April 2004)
Volume 13, Issue 6, Pages (June 2006)
Andrew Wilber, Michael Lu, Michael C. Schneider  Molecular Therapy 
Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury  Abigail K. Hanna, MD, Jonathan C. Fox, MD,
Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection  Xinying Tang, Hongbo Zhang,
Volume 8, Issue 6, Pages (December 2003)
FGF-7 Expression Enhances the Performance of Bioengineered Skin
Retroviral-mediated transduction of endothelial cells with the lac Z gene impairs cellular proliferation in vitro and graft endothelialization in vivo 
Volume 26, Issue 1, Pages (January 2018)
Volume 7, Issue 3, Pages (March 2003)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Receptor-Targeted Gene Delivery Using Multivalent Phagemid Particles
HIV-1 Vif: Counteracting Innate Antiretroviral Defenses
Volume 13, Issue 1, Pages (January 2006)
Volume 4, Issue 6, Pages (December 2001)
Thomas S. Griffith, Elizabeth L. Broghammer  Molecular Therapy 
Herpesvirus-Mediated Systemic Delivery of Nerve Growth Factor
Volume 5, Issue 6, Pages (June 2002)
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
The Effect of Size and Shape of RNA Nanoparticles on Biodistribution
Volume 8, Issue 6, Pages (December 2003)
Volume 12, Issue 4, Pages (October 2005)
Volume 10, Issue 4, Pages (October 2004)
Elizabeth M Hadac, Elizabeth J Kelly, Stephen J Russell 
Volume 6, Issue 5, Pages (November 2002)
Volume 13, Issue 1, Pages (January 2006)
Volume 8, Issue 2, Pages (August 2003)
Volume 18, Issue 8, Pages (August 2010)
Volume 12, Issue 5, Pages (November 2005)
Volume 26, Issue 2, Pages (February 2018)
Yunyuan Li, Edward E. Tredget, Abdi Ghaffari, Xiaoyue Lin, Ruhangiz T
Volume 4, Issue 6, Pages (December 2001)
Volume 15, Issue 10, Pages (October 2007)
Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?
Volume 19, Issue 5, Pages (May 2011)
Harry I Segall, Eunsun Yoo, Richard E Sutton  Molecular Therapy 
Volume 24, Issue 9, Pages (September 2016)
Volume 3, Issue 5, Pages (May 2001)
Zhijian Wu, Aravind Asokan, R. Jude Samulski  Molecular Therapy 
Development of Novel Formulations That Enhance Adenoviral-Mediated Gene Expression in the Lung in Vitro and in Vivo  Maria A. Croyle, Xuan Cheng, Arbans.
Volume 16, Issue 10, Pages (October 2008)
Volume 3, Issue 5, Pages (May 2001)
Volume 8, Issue 2, Pages (August 2003)
Molecular Therapy - Oncolytics
Volume 18, Issue 10, Pages (October 2010)
Volume 12, Issue 5, Pages (November 2005)
Presentation transcript:

Delivery and Protection of Adenoviruses Using Biocompatible Hydrogels for Localized Gene Therapy  Rachel Maddox Schek, Scott J Hollister, Paul H Krebsbach  Molecular Therapy  Volume 9, Issue 1, Pages 130-138 (January 2004) DOI: 10.1016/j.ymthe.2003.10.002 Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 1 Expression of β-gal demonstrates infection of cells by virus suspended in gels. Lac-Z virus was incubated in medium with 10% serum for (A) 0, (B) 2, or (C) 24 h or 0.5 mg/ml fibrin gel for (D) 0, (E) 2, or (F) 24 h before being exposed to cells. X-gal staining of these cells allowed visualization of the infected cells. Photographs demonstrate the decrease in number of infected cells as preincubation time was lengthened and that virus contained in fibrin gel was active for longer periods. Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 2 The activity of the adenovirus suspended in gel depends on the concentration and composition of gel. Rates of infection were assessed visually using image processing software. (A) Adenovirus was suspended in α-MEM and preincubated before being used to infect cells. Transduction levels declined rapidly with lengthened preincubation times. (B) Virus-containing collagen gels were preincubated with elution fluid; the fluid was removed and cells were seeded on the remaining gels. Infection levels dropped with longer preincubation times and transduction levels were consistently higher for the collagen concentration of 0.5 mg/ml (square) than for 2 mg/ml (circle). (C) Virus contained in fibrin gels exhibited a slower drop in infection rates over lengthened preincubation times. Infection levels were higher for the lower concentration of fibrin, 0.5 mg/ml (square), than for 5 (circle) or 25 mg/ml (triangle). Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 3 The concentration and composition of gel from which the virus eluted effects its bioactivity over time. (A) Elution fluid from the collagen gels applied to cells showed that infection levels drop as the preincubation time of the gel increases. Higher numbers of infected cells were observed for all incubation times for the 0.5 mg/ml (square) than for the 2 mg/ml (circle) gel. (B) Elution medium from the fibrin gels was applied to cells. For 5 (circle) and 25 mg/ml (triangle), a drop in transduction levels was observed as incubation times increased, but the 0.5 mg/ml (square) elution fluid showed consistently high transduction levels for up to 48 h of preincubation and measurable activity for more than 60 h. Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 4 Elution of viral DNA is much slower and less complete from collagen gel than from fibrin. Real-time PCR was used to quantify the viral DNA present in gels and elution fluids after periods of incubation at 37°C. Standards of known amounts of virus allowed interpolation of the number of viral particles in each sample. (A) Levels of viral particles contained in the collagen gel (white) remained much higher than in the elution medium (black) at all times. (B) In fibrin gel, viral particle levels decreased in the gel (white) and they increased in the elution medium (black). Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 5 Fibrin led to significantly more bone formation than either liquid or collagen. After 4 weeks, μCT analysis revealed the presence of bone in 4 of 5 of the fibrin-implanted muscles, 4 of 5 of the collagen-implanted muscles, and 5 of 10 of the liquid-implanted muscles. The volume of the ossicles that were formed using virus in fibrin was significantly larger than that of those formed using either collagen or liquid. No bone was formed in the 1- or 2-week implants. Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 6 Both collagen and fibrin gels serve as effective carriers for delivery of functional genes in vivo. Three-dimensional reconstructions of μCT data were used to calculate the volume of the bone formed after 109 viral particles of adenovirus coding for BMP-7 were suspended in culture medium, collagen, or fibrin gels and implanted into the quadriceps of immunocompromised mice. Hematoxylin and eosin staining confirmed (A) the absence of bone in negative control transplants and (B) the presence of ossicles in specimens implanted with the virus; (C) three dimensional rendering of the μCT data. Molecular Therapy 2004 9, 130-138DOI: (10.1016/j.ymthe.2003.10.002) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions